Artificial Intelligence-Assisted Colonoscopy in Colorectal Cancer Screening in a General Hospital

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45-74
SponsorChirec

About this trial

Cancer can develop in the colon, or large bowel. Examination of the colon with a tube fitted with a camera is called a colonoscopy.

Colonoscopy allows detection of small growths in the colon, called "polyps". Polyps can often be removed during colonoscopy. Some of these polyps are called adenomas and can become cancer after several years.

A good colonoscopy aims to find and take out as many of these polyps as possible.

A quality indication of colonoscopy is the "adenoma detection rate" (ADR). It should be high, meaning many polyps are detected and taken out.

New artificial intelligence devices to assist colonoscopy seem to increase the ADR, and maybe help prevent cancer even better than normal colonoscopy.

The goal of this clinical trial is to compare the ADR when using standard colonoscopy to the ADR with artificial intelligence (AI)-assisted colonoscopy.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Patient (woman or man) candidate for a screening colonoscopy - Age: 45 to 74 years included

Absence of inflammatory bowel disease

Absence of significant digestive symptoms indicating colonoscopy (i.e. screening is the only indication for the examination)

Patient able to understand the concept of the study and agreeing to participate

Disqualifiers

Patient outside the inclusion age

All exclusion criteria for a colonoscopy.

The indication for colonoscopy is not simple screening; for example, assessment of anemia, rectal bleeding, weight loss or abdominal pain.

Patient's refusal to participate, or patient's inability to understand the study concept

Trial design

Design model

Parallel

Treatments tested in this trial

  • conventional colonoscopy procedure

    Other intervention

    Study subjects in this interventional arm will undergo conventional colonoscopy.

  • artificial intelligence-assisted colonoscopy procedure

    Other intervention

    Study subjects in this interventional arm will undergo colonoscopy done with a commercially-available module that uses artificial intelligence to highlight suspected polyps on the screen during colonoscopy. This module also attempts to characterize the detected polyp as adenomatous or not. The detection and characterization of polyps is in real time, during the procedure.

Treatment groups

765 Participants
are divided into 2 treatment groups
Group A: CCP: conventional colonoscopy procedureActive comparator 1 intervention
Group B: ACP: artificial intelligence-assisted colonoscopy procedureActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Adenoma Detection Rate in Conventional versus Artificial Intelligence-Assisted Colonoscopy

The main objective of this study is the difference in the detection rate of colorectal adenomas in individuals over 45 years old during colonoscopies for colon cancer screening between a conventional colonoscopy procedure (CCP) and a colonoscopy procedure with AI (ACP).

Time frame
1 day

Secondary outcomes

1

The difference in the detection rate of colorectal adenomas according to size by group (5 mm/6-9 mm/>10 mm) between a conventional colonoscopic procedure (CCP) and a colonoscopy procedure with AI (ACP).

Detection rate of diminutive, small, and large polyps will be compared between a conventional colonoscopic procedure (CCP) and a colonoscopy procedure with AI (ACP).

Time frame
1 day
2

The difference in the detection rate of colorectal adenomas according to the number per group (n=1-2/n= 3-10/n >10) between a conventional colonoscopic procedure (CCP) and a colonoscopy procedure with AI (ACP).

The number of adenomas detected during the procedure will be compared between a conventional colonoscopic procedure (CCP) and a colonoscopy procedure with AI (ACP).

Time frame
1 day
3

The difference in the detection rate of colorectal adenomas based on histology by group (hyperplastic/conventional adenomas/serrated adenomas/adenocarcinoma) between a conventional colonoscopic procedure (PCC) and a colonoscopy procedure with AI.

Adenomas have different histologic types. After obtaining histology, the detection rate of the various histologic types will be compared between a conventional colonoscopic procedure (CCP) and a colonoscopy procedure with AI (ACP).

Time frame
1 month
4

The difference in detection rate of colorectal adenomas based on dysplastic grade by group

The difference in detection rate of colorectal adenomas based on dysplastic grade by group (conventional or serrated adenomas/low-grade dysplasia/high-grade dysplasia/adenocarcinoma) or Narrow Band Imaging International Colorectal Endoscopic (NICE) (stages 1, 2 or 3) classification or Japan Narrow Band Imaging Expert Team (JNET) classification (stages 1, 2A and 2B, or 3) between a conventional colonoscopy procedure (CCP) and a colonoscopy procedure with AI (ACP).

Time frame
1 day

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: